Sarcoidosis-like reaction induced by immune checkpoint inhibitors in patients with advanced melanoma: A report of two cases and a brief review of the literature

Introduction. Immunotherapy is associated with a wide range of adverse events. A drug-induced sarcoidosis-like reaction is a systemic granulomatous reaction that is no different from sarcoidosis and occurs in a certain temporal relationship with the initiation of the drug. Case report. The first pre...

Full description

Saved in:
Bibliographic Details
Main Authors: Dujović Branko, Kandolf Lidija, Radević Tatjana, Petrov Nenad, Mijušković Željko
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2025-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:https://doiserbia.nb.rs/img/doi/0042-8450/2025/0042-84502400080D.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850234806728654848
author Dujović Branko
Kandolf Lidija
Radević Tatjana
Petrov Nenad
Mijušković Željko
author_facet Dujović Branko
Kandolf Lidija
Radević Tatjana
Petrov Nenad
Mijušković Željko
author_sort Dujović Branko
collection DOAJ
description Introduction. Immunotherapy is associated with a wide range of adverse events. A drug-induced sarcoidosis-like reaction is a systemic granulomatous reaction that is no different from sarcoidosis and occurs in a certain temporal relationship with the initiation of the drug. Case report. The first presented patient was a 61-year-old male with stage IIIC BRAF-positive melanoma treated with adjuvant nivolumab therapy. After four cycles of therapy, enlarged mediastinal lymph nodes were confirmed using computed tomography. Bronchoscopy with bronchoalveolar lavage and transbronchial biopsy showed chronic granulomatous inflammation. After 12 cycles, grouped brownish-red papules and plaques covered with whitish scales were observed in the skin of both knees, and a histopathology finding indicated a sarcoidosis-like reaction. He was treated with oral prednisone, 60 mg daily in decreasing doses, and after 16 months, the enlarged mediastinal lymph nodes and skin lesions disappeared completely. The second presented patient was a 45-year-old male with stage IIIC BRAF-positive melanoma treated with adjuvant pembrolizumab therapy. After four cycles, enlarged mediastinal lymph nodes were observed. Bronchoscopy with bronchoalveolar lavage revealed granulomatous inflammation, and transbronchial biopsy confirmed sarcoidosis. Therapy with oral prednisone 40 mg daily in decreasing doses was performed in the next three months, and immunotherapy was continued. The enlarged mediastinal lymph nodes resolved after completion of adjuvant therapy. Conclusion. In most cases, a diagnosis of a sarcoidosis-like reaction requires a biopsy of the suspected lesions. It is not usually necessary to stop immunotherapy, but sometimes standard corticosteroid therapy is indicated. An interdisciplinary approach is important to distinguish true disease progression from adverse drug reaction.
format Article
id doaj-art-c4dc01caf52647a3b7ae1e942f1fae60
institution OA Journals
issn 0042-8450
2406-0720
language English
publishDate 2025-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-c4dc01caf52647a3b7ae1e942f1fae602025-08-20T02:02:30ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502406-07202025-01-01821465310.2298/VSP240726080D0042-84502400080DSarcoidosis-like reaction induced by immune checkpoint inhibitors in patients with advanced melanoma: A report of two cases and a brief review of the literatureDujović Branko0https://orcid.org/0009-0009-1497-5777Kandolf Lidija1https://orcid.org/0000-0002-5221-5068Radević Tatjana2https://orcid.org/0000-0001-9259-3031Petrov Nenad3Mijušković Željko4https://orcid.org/0000-0003-0924-1719Military Medical Academy, Department of Dermatology and Venereology, Belgrade, Serbia + University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, SerbiaMilitary Medical Academy, Department of Dermatology and Venereology, Belgrade, Serbia + University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, SerbiaMilitary Medical Academy, Department of Dermatology and Venereology, Belgrade, Serbia + University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, SerbiaMilitary Medical Academy, Center of Pathology and Forensic Medicine, Belgrade, SerbiaMilitary Medical Academy, Department of Dermatology and Venereology, Belgrade, Serbia + University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, SerbiaIntroduction. Immunotherapy is associated with a wide range of adverse events. A drug-induced sarcoidosis-like reaction is a systemic granulomatous reaction that is no different from sarcoidosis and occurs in a certain temporal relationship with the initiation of the drug. Case report. The first presented patient was a 61-year-old male with stage IIIC BRAF-positive melanoma treated with adjuvant nivolumab therapy. After four cycles of therapy, enlarged mediastinal lymph nodes were confirmed using computed tomography. Bronchoscopy with bronchoalveolar lavage and transbronchial biopsy showed chronic granulomatous inflammation. After 12 cycles, grouped brownish-red papules and plaques covered with whitish scales were observed in the skin of both knees, and a histopathology finding indicated a sarcoidosis-like reaction. He was treated with oral prednisone, 60 mg daily in decreasing doses, and after 16 months, the enlarged mediastinal lymph nodes and skin lesions disappeared completely. The second presented patient was a 45-year-old male with stage IIIC BRAF-positive melanoma treated with adjuvant pembrolizumab therapy. After four cycles, enlarged mediastinal lymph nodes were observed. Bronchoscopy with bronchoalveolar lavage revealed granulomatous inflammation, and transbronchial biopsy confirmed sarcoidosis. Therapy with oral prednisone 40 mg daily in decreasing doses was performed in the next three months, and immunotherapy was continued. The enlarged mediastinal lymph nodes resolved after completion of adjuvant therapy. Conclusion. In most cases, a diagnosis of a sarcoidosis-like reaction requires a biopsy of the suspected lesions. It is not usually necessary to stop immunotherapy, but sometimes standard corticosteroid therapy is indicated. An interdisciplinary approach is important to distinguish true disease progression from adverse drug reaction.https://doiserbia.nb.rs/img/doi/0042-8450/2025/0042-84502400080D.pdfbiopsydiagnosisdifferentialdisease progressiondrug-related side effects and adverse reactionsmelanomasarcoidosis
spellingShingle Dujović Branko
Kandolf Lidija
Radević Tatjana
Petrov Nenad
Mijušković Željko
Sarcoidosis-like reaction induced by immune checkpoint inhibitors in patients with advanced melanoma: A report of two cases and a brief review of the literature
Vojnosanitetski Pregled
biopsy
diagnosis
differential
disease progression
drug-related side effects and adverse reactions
melanoma
sarcoidosis
title Sarcoidosis-like reaction induced by immune checkpoint inhibitors in patients with advanced melanoma: A report of two cases and a brief review of the literature
title_full Sarcoidosis-like reaction induced by immune checkpoint inhibitors in patients with advanced melanoma: A report of two cases and a brief review of the literature
title_fullStr Sarcoidosis-like reaction induced by immune checkpoint inhibitors in patients with advanced melanoma: A report of two cases and a brief review of the literature
title_full_unstemmed Sarcoidosis-like reaction induced by immune checkpoint inhibitors in patients with advanced melanoma: A report of two cases and a brief review of the literature
title_short Sarcoidosis-like reaction induced by immune checkpoint inhibitors in patients with advanced melanoma: A report of two cases and a brief review of the literature
title_sort sarcoidosis like reaction induced by immune checkpoint inhibitors in patients with advanced melanoma a report of two cases and a brief review of the literature
topic biopsy
diagnosis
differential
disease progression
drug-related side effects and adverse reactions
melanoma
sarcoidosis
url https://doiserbia.nb.rs/img/doi/0042-8450/2025/0042-84502400080D.pdf
work_keys_str_mv AT dujovicbranko sarcoidosislikereactioninducedbyimmunecheckpointinhibitorsinpatientswithadvancedmelanomaareportoftwocasesandabriefreviewoftheliterature
AT kandolflidija sarcoidosislikereactioninducedbyimmunecheckpointinhibitorsinpatientswithadvancedmelanomaareportoftwocasesandabriefreviewoftheliterature
AT radevictatjana sarcoidosislikereactioninducedbyimmunecheckpointinhibitorsinpatientswithadvancedmelanomaareportoftwocasesandabriefreviewoftheliterature
AT petrovnenad sarcoidosislikereactioninducedbyimmunecheckpointinhibitorsinpatientswithadvancedmelanomaareportoftwocasesandabriefreviewoftheliterature
AT mijuskoviczeljko sarcoidosislikereactioninducedbyimmunecheckpointinhibitorsinpatientswithadvancedmelanomaareportoftwocasesandabriefreviewoftheliterature